Profile
Dr. Manoj Ramjee is Chief Operating Officer at Amura Holdings Ltd.
Dr. Ramjee was previously employed as Vice President-Biochemsitry by Amura Therapeutics Ltd., a Director-Biological Chemistry by Acambis Plc, and a Research Associate by University of Cambridge.
He received his undergraduate degree from Imperial College London and a doctorate degree from the University of Sussex.
Former positions of Manoj Ramjee
| Companies | Position | End |
|---|---|---|
| University of Cambridge | Corporate Officer/Principal | - |
| Amura Therapeutics Ltd. | Corporate Officer/Principal | - |
Acambis Plc
 Acambis Plc BiotechnologyHealth Technology Acambis Plc develops biopharmaceutical products and vaccines. It offers ACAM2000, a smallpox vaccine for emergency-use stockpiling; and ChimeriVax-JE, a single-dose Japanese encephalitis vaccine for endemic markets and travelers. Its products in pipeline include ChimeriVax-JE, ChimeriVax-West Nile, and ChimeriVax-Dengue. The company was founded in 1992 and is headquartered in Cambridge, UK. | Corporate Officer/Principal | - |
Amura Holdings Ltd.
 Amura Holdings Ltd. Pharmaceuticals: MajorHealth Technology Amura Holdings Ltd. was engaged in drug discovery for diseases, such as osteoporosis, osteoarthritis, bone metastasis, autoimmunity, chronic pain, and malaria. The firm developed a technology platform that provided turnkey solutions for the discovery of small-molecule inhibitors against cysteine peptidases. The company was founded by Daniel James William Roach on June 6, 20005 and was headquartered in Cambridge, the United Kingdom. | Chief Operating Officer | - |
Training of Manoj Ramjee
| Imperial College London | Undergraduate Degree |
| University of Sussex | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Acambis Plc
Acambis Plc BiotechnologyHealth Technology Acambis Plc develops biopharmaceutical products and vaccines. It offers ACAM2000, a smallpox vaccine for emergency-use stockpiling; and ChimeriVax-JE, a single-dose Japanese encephalitis vaccine for endemic markets and travelers. Its products in pipeline include ChimeriVax-JE, ChimeriVax-West Nile, and ChimeriVax-Dengue. The company was founded in 1992 and is headquartered in Cambridge, UK. | Health Technology |
Amura Holdings Ltd.
Amura Holdings Ltd. Pharmaceuticals: MajorHealth Technology Amura Holdings Ltd. was engaged in drug discovery for diseases, such as osteoporosis, osteoarthritis, bone metastasis, autoimmunity, chronic pain, and malaria. The firm developed a technology platform that provided turnkey solutions for the discovery of small-molecule inhibitors against cysteine peptidases. The company was founded by Daniel James William Roach on June 6, 20005 and was headquartered in Cambridge, the United Kingdom. | Health Technology |
| Amura Therapeutics Ltd. |
- Stock Market
- Insiders
- Manoj Ramjee
